Appropriate antimicrobial treatment of shigellosis depends on identifying its changing resistance patternovertime.Weevaluated15,255stoolculturesubmittedfromJuly2001toJune2006tothe LaboratoryofChildrenMedicalCenterHospital.Specimenculture,bacterialidentiication,anddisk diffusionsusceptibilitytestingwereperformedaccordingtoNationalCommitteeforClinicalLabo-ratoryStandardsguidelines.From15,255stoolsamples,682(4.5%)werepositiveforShigellaspecies.ThemostcommonspeciesofShigellawereS.flexneri(48%)andS.sonnei(45%);otherresults wereS.dysenteriae(5%)andS.boydii(2%).TherateofSensitivitytoceftriaxone(95%),ceftizoxime (94%),andnalidixicacid(84%)wereamongourisolates.Resistancetoco-trimoxazoleandampicil-linwas87%and86%,respectively.S.flexneriwasmoremultiresistantthanotherspecies(47.9%). Ourisolatesareoverallmostsensitivetoceftriaxone,ceftazidime,andnalidixicacid(>84%).They weremostresistanttoco-trimoxazoleandampicillin(>86%).Becauseresistancevariesaccordingto speciiclocation,continuouslocalmonitoringofresistancepatternsisnecessaryfortheappropriate selectionofempiricalantimicrobialtherapy.
INTRODUCTION
Dysentery caused by Shigella species is called shigellosis,whichisoneofthemostcommon causesofdysenteryinchildren.Itisresponsible forincreasedcasesofmorbidityandmortality indevelopingcountries.Globalstudiessuggest there are 164.7 million episodes of shigellosis peryear,ofwhich163.2millionwereindevelopingcountries,and1.5millionindeveloped countries.Theseepisodesresultin1.1million deaths, of which two-thirds occur in children under5yearsofage. 1 The epidemiology and antibiotic susceptibility of Shigella species changes over time. Treatment of shigellosis by appropriate antimicrobial agents has proven to be effective in shorteningthedurationoffever,diarrheaand toxemia,andapparentlyinreducingtheriskof lethalcomplicationsaswell.Also,theexcretion ofpathogeninstoolisshortenedsigniicantly, reducing the spread of infection. 2 Appropriateantibiotictreatmentofshigellosisdepends onidentifyingresistancepatterns.So,updated knowledge of Shigella susceptibility is neces-saryforappropriateempiricalantibiotictreatment.Inthisstudy,weassessedthefrequency of Shigella species and their antimicrobial resistance at Children's Medical Center (CMC) HospitalbetweenJuly2001andJune2006.The aims of this study were to analyze antimicrobial resistance of Shigella isolates to suggest timelyrecommendationsforempiricalantibiotictherapy.
MATERIAL AND METHODS

Source of specimens
We evaluated 15,255 stool culture submitted fromJuly2001toJune2006totheLaboratory ofCMCHospital.OnlyoneShigellaisolateper patient per diarrheal episode was included in the analysis. All the included patients lived in Tehranatthetimeofstudyandtheywerenot hospitalized or received any antibiotic during themonthbeforepresentationwithshigellosis. Inadditiontobeingareferraltertiarycarecentre,CMCHospitalisoneoftheeducationalhos-pitalsofTehranUniversityofMedicalSciences.
Microbial examination
Stool specimens were cultured on Salmonella-Shigella (SS)AgarandEosinmethyleneblue(EMB)agarandincubated at 37° C for 1 to 5 days. Biochemical tests were done by standard methods on grown bacteria to identify Shigella species, which grouped serologically by slide agglutination with speciic antisera. Antibiotic susceptibility to ceftazidime, tobramycin, ceftizoxime, ceftriaxone, chloramphenicol, kanamycin, nalidixic acid, cephalothin, co-trimoxazole,ampicillin,gentamicinandamikacinwas determinedinallspecimensbydiscdiffusionmethodac-cordingtotheNationalCommitteeforClinicalLaboratory Standards (NCCLS). 3 To verify that susceptibility test results were accurate, we used E. coli ATCC 25922 as con-trolstrainaccordingNCCLSguideline. 3 lin and co-trimoxazole. 5 Antimicrobial susceptibility results were rounded down if < 0.5 and were presented as wholenumbersif≥0.5.
Statistical analysis
The signiicance of differences in proportions of antimi-crobialresistanceofShigellaspecieswasdeterminedbythe chi- squaretestortheFisherExacttest(whentheexpected valuein>20%ofthecellswas<5).P-value<0.05wasconsidered statistically signiicant. Statistical calculations were performedwithSPSSstatisticalsoftware(version13.0;SPSS Inc.,Chicago,IL,USA).
RESULTS
From 15,255 stool samples, 682 (4.5%) were positive for Shigellaspecies.Thespeciesof397outof682Shigellaisolatesweredetermined.ThemostcommonspeciesofShigella wasS.flexneri(48%)andS.sonnei(45%),andotherresults wereS.dysenteriae(5%)andS.boydii(2%)(Table1).Shigellaisolatesweretotallymostsensitivetoceftriaxone(95.4%), ceftizoxime(94%),andnalidixicacid(83.5%);andmostresistant to co-trimoxazole (87%) and ampicillin (86%).All resultsareshowninTable2.S.flexneriwasmostsensitiveto Ceftriaxone (94%), Ceftizoxime (90%), and Nalidixic acid (89%);andmostresistanttoAmpicillin(96%)andCo-trimoxazole(90%).Comparingtheresultsofsusceptibilityby yearoverthestudyperiod,itwasfoundincreaseofratesof resistancetocefazolin,ceixime,tobramycin,amikacininS. flexneriisolates(p-value<0.05).S.sonneiwasmostsensitive toceftizoxime(98%),ceftriaxone(97%),andchlaromphenicol(93%);andmostresistanttoco-trimoxazole(92%)and ampicillin (73%). These isolates comparing the results of susceptibilitybyyearshowedincreaseofratesofresistance to kanamycin, cefalotin, ampicillin, gentamycin, amikacin, ceftriaxone, ceftazidime, tobramycin (p-value < 0.05). S. dysenteriae was completely sensitive to ceftriaxone, ceftizoxime, cephalotine, co-trimoxazole (100%), and it was mostresistanttokanamycin(100%),amikacin(63%),and nalidixicacid(63%).S.boydiiwastotallysensitivetogentamicin,amikacin,ceftriaxone,ceftizoxime,ceftazidime,and tobramycin (100%); and most resistant to co-trimoxazole (75%),cephalotine(75%),ampicillin(63%),andkanamycin(60%)(Table3).InS.dysenteriaeandS.boydiiisolates werenotseenanyvaluablesigniicanceinrateofresistance when comparing the results by the years.Among 682 isolates,500isolatesweremultiresistant(74%).S.flexneriwas moremultiresistantthanotherspecies(Table4).
DISCUSSION
Fromtheepidemiologicperspective,Shigellaisapathogen thatpersistsasamajorpublichealthproblemindeveloping countries, causing treatment center visits, hospitalizations, anddeaths,althoughitalsoremainsanintermittentcause ofmorbidityandmortalityinhighriskgroupsinindustrializedcountries. S.sonneiisthepredominantShigellaspeciesisolated in developed countries, 2,6,7 whereas in developing countries and low socio-economic conditions, S. flexneri predominates. 1, 2, 6, [8] [9] [10] In our study, S. flexneri (48%) was the most common, followed by S. sonnei (45%). Other specieswererare(S.dysenteriaeandS.boydii5%and2%, respectively).
Our isolates are overall most sensitive to ceftriaxone, ceftazidimeandnalidixicacid(>84%).Theyweremostresistanttoco-trimoxazoleandampicillin(>86%)whichwas compatiblewithotherstudies. 1, 2, 5 Antibioticsusceptibilityresultsaretosomeextentdifferentamongdifferentspecies. S.flexneri,themostcommon species,wasmostsensitivetoceftriaxone,ceftizoxime,and nalidixicacid;andS.sonneiwasmostsensitivetoceftizoxime,ceftriaxone,andchloramphenicol.S.flexneriwasmore sensitivetonalidixicacidthanS.sonnei(p-value<0.05)and S. sonnei was more sensitive to cephalosporines (ceftizoxime, ceftriaxone, ceftazidime, cephalotine) than S. flexneri (p-value<0.05).Itshowsthatforanempirictherapy,when the suspected species is S. flexneri, nalidixic acid will be moreeffectiveanditsresistancetrendoverthestudyperiod had not valuable signiicance, while third cephalosporines will be more effective than nalidixic acid in treatment of shigellosis due to S. sonnei. S. flexneri and S. sonnei were mostresistanttoampicillinandco-trimoxazole.S.flexneri was more resistant to ampicillin than S. sonnei (p-value <0.0001).Otherreportsfromallovertheworldalsoindicate 13 Inourstudy,allShigellaspecieswere sensitive to chloramphenicol, except S. flexneri, which was resistanttoit(68%).Ampicillinandchloramphenicolwere the inexpensive and broad-spectrum antimicrobial agents commonlyusedindevelopingcountries.Increaseofresistancetoampicillinorchloramphenicolisoftenrelatedwith extensiveuseoftheseantimicrobialagents. 1 This information is important because S. flexneri and S.sonneiarethemostcommonspeciesanditshouldbetakenintoaccountfortreatment.Co-Trimoxazoleisacommon drugusedasanempirictherapyintreatmentofshigellosis andotherdiarrhealdiseasesofbacterialorigins.Theextensive use of this drug has contributed to the emergence of resistantS.sonneiandsustainedtheresistanttrait. 1, 15, 16 In addition to co-Trimoxazole and ampicillin, ongoing resistanceofShigellaspeciestotetracycline,chloramphenicol,andmostrecentlytofluoroquinoloneshasbeenshown. Oral aminoglycosides and irst and second generation cephalosporinsareclinicallyineffective,despitetheirinvitro activity. 5, [17] [18] [19] [20] [21] In our study Shigella species were sensitive to aminoglycosides,exceptkanamycin.Kanamycinisamemberofaminoglycosides,whichresistancetoitwasreported beforebyLeeet al. ( )andJeonget al.(2003 . 22, 23 They hadreportedtheemergenceofkanamycin-resistantS.son-neiisolatesinKorea. 1 Althoughresistancetofluoroquinoloneshasbeenrarelyreported,nearlyallShigellaisolatesare susceptible to these agents. Indeed, quinolones, which are also eficacious against other causes of bacterial gastroenteritis,areoftenrecommendedasempiricaltherapyinareas withhighresistancetoShigellaspp.Theyare,however,not approvedforchildrenbecauseofthepotentialriskofdamagetogrowingcartilage. 2, 6, 24 Anothersuitableantibioticfor treatment in children with severe shigellosis, especially in thosewhoarehospitalized,isparenteralceftriaxone,which iseffectiveandusuallyrecommended. 2 Inthisstudy,Shigella species(esp.S.dysenteriaeandS.boydii)hadhighsensitivity toceftriaxone.
In milder cases in children, choosing the optimal oral therapyismoreproblematicandshouldbebasedonlocal epidemiologicaldata.Nalidixicacidorextendedspectrum cephalosporins are usually adequate. 2 In our study, Shigella species (esp. S. dysenteriae and S. boydii) were highly sensitive to third generation cephalosporins (ceftiaxone, ceftizoxime, ceftazidime). Despite some studies that has reported resistance to nalidixic acid (esp. about S. flexneri andS.dysenteriae), 8, 9, 25 Shigellaspecieswerealsosensitiveto nalidixicacid,andS.flexneriisolateswereevenmoresensitivetoitthanotherspecies.Thisdatamakesnalidixicacid stilloneofthemostappropriateantibioticsfortreatmentof shigellosisduetoShigellaspecies'sensitivitytoit,itscostand itseasyaccessibilityinIran.S.dysenteriaecausesoneofthe most severe forms of epidemic severe dysenteries. 26 It was mostsensitivetoceftriaxone,ceftizoxime,cephalotine,and co-trimoxazole;andmostresistanttokanamycin,amikacin andnalidixicacid.
Multiresistancetotheantimicrobialagentsusedintreatmentofshigellosishasbeenreportedinmanypartsofthe world. 1, 22, 23, 27, 28 Inourstudy,S.flexneriwasmoremultiresistantthanotherspecies,whichisveryimportantduetoitsfrequency.Ceftriaxoneandciprofloxacinhavebeenshownto be highly effective for shigellosis. 5, [29] [30] [31] Ceftriaxone requires parenteraladministration,whereasciprofloxacinisavoided inchildren. TheincreasingrelativeprevalenceofShigellaspeciesand the emergence of new resistant strains pose a clear public healthproblem.Asresistancetoantimicrobialagentschanges constantly, it is important to keep these strains under surveillanceinordertomonitorthelocalsusceptibilityand subsequentlyformulatepoliciesfortherationaluseofantimicrobialagents.
